Skip to main content

A survey of ethnomedicinal plants used to treat cancer by traditional medicine practitioners in Zimbabwe



Traditional medicine plays an important role in health care provision in the developing world. A number of cancer patients have been found to be using traditional medicine as primary therapy and/or as complementary medicine. Cancer is one of the leading causes of morbidity and mortality globally among the non-communicable diseases. The aim of this study was to identify the plants used by traditional medicine practitioners (TMPs) in Zimbabwe to treat cancer.


A structured questionnaire was used to interview consenting registered TMPs on ethnomedicinal plants they use to treat cancer. A review of published literature on the cited plants was also carried out. The practitioners were asked about the plants that they use to treat cancer, the plant parts used, type of cancer treated, other medicinal uses of the plants and preparation and administration of the plant parts.


Twenty (20) TMPs took part in the study. A total of 18 medicinal plant species were cited. The commonly treated types of cancer were breast, prostate, colon, skin and blood cancers with most plants being used to treat skin, blood and breast cancers, respectively. Of the medicinal plants cited, 44.4% were used to treat all cancer types. The most used plant parts were the roots (72.2%) and leaves (72.2%) followed by the bark (38.9%). The medicinal plants were used for multiple ailments. The most common plant preparation methods were infusion (72.2%) and decoction (66.7%) and the oral route of administration, as extracts and powder put in tea and porridge, was the most used.


The frequently used plant parts were leaves and roots. The traditional uses of the medicinal plants cited in this study resonate well with their reported uses from other ethnopharmacological studies done in other parts of the world. The plants used by TMPs to treat cancer in Zimbabwe, if adequately explored, can be instrumental in the discovery and development of cancer drugs.

Peer Review reports


Traditional medicine refers to ways of protecting and restoring health that existed before the arrival of modern medicine [1]. The World Health Organisation (WHO) defines traditional medicine as native health practices, approaches, knowledge and beliefs that maybe applied either singular or in combination to treat, diagnose and maintain wellbeing [2]. It plays an important role in health care provision in the developing world and its use is also now significant in developed countries thus increasing commercial value. Traditional herbal medicines are naturally occurring plant and animal based substances with minimal or no industrial processing that are used to treat diseases within some healing practices [3]. Some people rely on these medicines to meet their health requirements. According to WHO, a third of the world’s population has no regular access to essential modern medicine [4]. In parts of Africa, Asia and Latin America, it is estimated that about half of the population faces shortages of minimum healthcare; due mainly to inadequacies in healthcare financing by the governments. This poses for glaring inequities in healthcare delivery in developing countries. Heavy burden of communicable diseases (HIV/AIDS, malaria, TB, pneumonia, diarrhoeas) coupled with the advent of growing threat of non-communicable diseases (NCDs) such as diabetes, cancer, hypertension, ischemic heart diseases; amongst many others, torment lives in developing countries [5]. The use of ethnomedicinal plants contribute to primary healthcare of people of the area that they are found [6] and thus contribute a rich health to human beings. About 80% of people living in rural settings in developing countries use traditional medicine for their primary health care needs [7, 8] and, generally, a number of cancer patients have been found to be using traditional medicine as primary therapy and/or as complementary medicine [9, 10].

A number of anticancer agents of plant origin, such as taxol, vincristine, vinblastine, etoposide, irinotecan and topotecan, are being used in clinical practice. Researches on ethnomedicine used to treat cancer continue to be pursued world over and the National Cancer Institute (NCI) is playing a huge role in research on medicinal plants used to treat cancer. The NCI has collected about 35,000 plant samples from 20 countries and screened, approximately, 114,000 extracts for anticancer activity [11]. All these efforts are because plant medicine plays a pivotal role in drug discovery and development. Also, these researches are meant to substantiate the medicinal claims and, on the other hand, help come up with well packaged finished drug products with well-defined dosage regimens for patients.

Cancer is the second leading cause of morbidity and mortality in the world amongst the NCDs [12,13,14,15]. A number of cancer deaths have been projected to increase from 7 million in 2002 to 11.5 million in 2030 [14]. Cancer is associated with the deterioration of quality of life, not only of the patients themselves, but also of spouse caregivers. Its diagnosis, length of hospitalisation, caregiving intensity and duration has a significant impact in determining the quality of life of spouse caregivers [16]. Treatment of the disease with some agents has been associated with deterioration of quality of life as well as induction of fatigue and some peripheral neuropathy; among a number of significant adverse effects. Common anti-cancer medicines frequently cause induction of a chemotherapy-induced peripheral neuropathy (CIPN) in which both large and small primary afferent sensory neurons are injured [17], while others are known to suppress the bone marrow; making the patients prone to infections and other diseases. Thus, development of medicines which offer optimal therapy of a condition and not have a negative impact on the quality of life of patients is of great importance. Many patients tend to complement or, in some instances, shun their conventional therapy with/for traditional medicine in an effort to minimise adverse effects.

A large proportion of the population in many developing countries relies on traditional practitioners and use of medicinal plants in order to meet healthcare needs. This is due to easy accessibility, efficacy on treatment and affordability in getting health services [18]. These traditional medicines have become more widely available commercially, especially in developed countries. In some countries, the production of these medicines is subjected to rigorous manufacturing standards [19]. Information about traditional medicine has been passed on from generation to generation mainly orally without substantive documentation. Some information could have been lost due to lack of documentation. Reliance on wild medicinal plants for primary healthcare by most communities has contributed to the continued preservation of knowledge of medicinal plants [20]. Documentation of the indigenous knowledge systems (IKS) on traditional medicine may assist in preserving medicinal plants and also patenting the IKS. The recognition of IKS is crucial for economic and cultural empowerment of indigenous people in particular, and the world at large. Incorporating indigenous knowledge into relevant policies such as health or climate policies can lead to the development of effective adaptation strategies that could be cost-effective, participatory and sustainable [21].

Despite the growing wide use of traditional medicine in Zimbabwe, the indigenous medicine knowledge on medicinal plants used to treat cancer is not widely documented. This prompted this particular ethnobotanical survey in an effort to address the gap. Documentation ensures that the traditional medicine knowledge is preserved and consequently leads to medicinal plants conservation. It also makes it easy for other subsequent studies that may focus on testing for activity of the identified plants against the claims.


Study area and data collection

The ethnomedicinal explorative study was conducted in the ten provinces of Zimbabwe. Practitioners were identified from the Traditional Medicine Practitioners Council (TMPC,) which falls under the Ministry of Health and Child Care (MoHCC). Convenience sampling was employed where participants (practitioners) available and willing to participate in the study were recruited and orally interviewed using a questionnaire as the instrument. Traditional medicine practitioners (TMPs) were visited in their homes and all present were invited for interviews. Before inclusion, the purpose of the study was explained to the TMPs. The researcher emphasized the enormous value which the TMPs (traditional healers and herbalists) input and contribution could make to the study as well as adding value to the already existing indigenous knowledge on traditional medicine practice in Zimbabwe. Data on the herbal plants used to treat cancer by consenting TMPs were recorded during visits to the practitioners. They were asked for knowledge about plants that they use against cancer, types of cancer treated, the plant parts used, methods of preparation and other medicinal uses of the plants. A taxonomist with the National Herbarium assisted with scientific names of plants cited using local names by some practitioners. This study mainly focused on data on medicinal plants used by TMPs to treat cancer. No plant samples were collected.

Ethical approval for the study was sort and obtained from Joint Research Ethical Committee for the University of Zimbabwe College of health Sciences and the Parirenyatwa Group of Hospitals (JREC), Medical Research Council of Zimbabwe (MRCZ) and the Traditional Medicine Practice Council (TMPC) of Zimbabwe. The researchers complied with the Convention on International Trade in Endangered Species of Wild Fauna and Flora.

Use value of the medicinal plants was determined by the frequency index (FI).

\( FI=\left(\frac{FC}{N}\right)\times 100 \). Where, FC is the number of participants who mention a particular plant species and N is the total number of participants [22].

Review of published literature; in the form of scientific journals, books and reports from international organisations; on the medicinal plants used by practitioners in the ethnomedicinal survey, was carried out.


Demographics of the TMPs

As shown in Table 1, a total of 20 certified practitioners, 15 traditional healers, 4 herbalists and 1 naturopathologist, participated in the study. All fell under MoHCC’s TMPC. There were more male (75%) than female (25%) practitioners who participated in the study and confessed knowledge of plants that can be used to treat cancer. Most practitioners were above 50 years of age (mean = 64 ± 7.87) and a few were in the age range of 30–50 years (mean = 44 ± 7.01). None who could be below 30 years of age took part in the study. On educational level of the participants; the highest number (8 in 20) had attained secondary level, followed by primary and tertiary level practitioners; both categories had a frequency of 6 in 20 each. The participants belonged to varying religious groups; ranging from traditional, Moslem to Christianity. Among the participants, 60 and 10% claimed to be Christians and Moslems, respectively; whilst 30% claimed to follow the traditional way of worship. In terms of practice experience, 8 in every 10 practitioners had more than 20 years of experience in herbal medicine practice and all the practitioners interviewed had at least 5 years’ experience in their trade.

Table 1 Demographic details of respondents (n = 20)

Perceptions or understanding of characteristics of cancer

Most of the practitioners who participated in the study claimed to know and understand the disease, cancer. However, some relied on diagnosis or confirmation from doctors or hospitals. Most patients who visit the practitioners would have been diagnosed and tried conventional treatment before their visits. .

In describing what leads them to cancer diagnosis in patients, 8 practitioners highlighted chronic deep wounds which tend to widen over time. Other symptoms such as severe chronic pain of no specific origin, which occurs concurrently with tissue wasting and general loss of appetite, were given by 7 TMPs as indicators for cancer. Most TMPs associated painful breast lumps with breast cancer. Sixteen participants claimed to treat all forms of cancer. A few of the participants claimed that they were always successful in their management of any form of the disease, cancer. However, a substantial number alluded to the fact that sometimes their medicines may fail to yield the desired results and would refer the patients to conventional hospitals or superior practitioners.

The most common types of cancer encountered by the practitioners in their years of practice were breast, prostate, colon, skin cancer and cancer of the blood.

Medicinal plants cited: Medicinal plants cited in this study are shown in Table 2.

Cited plants’ literature-reported medicinal uses or pharmacological activities: The medicinal uses or pharmacological activities, reported in literature, of the cited plants are indicated in Table 3.

Plants’ use value

The use value of the cited plants is given in Table 4. The plant species with more citations, indicated by relatively higher frequency indexes (FI), were said to have better use value than the ones with fewer citations or less FI. As such, Cannabis sativa L., Steganotaenia araliacea Hochst., Heteromorpha trifoliata (Wendl.)Eckl. & Zeyh., Kigelia africana (Lam.) Benth.., Bulbinella floribunda (Thunb.) T.Durand. & Schinz., Solanum incanum L., Pseudolachnostylis maprounelifolia Pax [Agg]. and Burkea africana Hook., with more than one citation, had more use-value than the others in this study.

Table 2 Medicinal plants cited
Table 3 Cited plants’ literature-reported medicinal uses or pharmacological activities
Table 4 Use value of the cited medicinal plants

Medicinal plant parts used

The different plant parts used by TMPs to make their medicinal products for patient administration are shown in Table 5. These plant parts include leaves, roots, bark, seeds, the fruit and, in one case, the whole plant. The leaves and roots were the most used plant parts among the plants cited. In 13 plant species (72.2%), roots and leaves were the useful plants parts, in 7 plant species (38.9%), the bark was used; whilst seeds and fruits were the plant parts used in 5 (27.8%) and 4 (22.2%) plant species. It was also noted that, as shown in Table 3, these plant species were not only useful for treatment of cancer, but also, for multiple other medical ailments. A single plant could be used for more than one ailment. It was also important to note that, out of the plant species obtained in this study, a number of them were cultivated or brought from neighbouring countries such as South Africa and Botswana by some of the practitioners, namely herbalists. These plants could no longer be easily found in the wild, locally. These species included Sutherlandia frutescens (L.)R.Br., Prunus persica (L.) Batsch, Duranta erecta L., Bulbinella floribunda (Thunb.) T. Durand & Schinz, Cannabis sativa L. and Hibiscus sabdariffa L.

Table 5 Parts of medicinal plants used to treat cancer

Types of cancer treated

Table 6 shows the different plant species that were used by the TMPs in this study, to treat different types of cancer. Eight [8] plant species (44.4%) were used to treat skin cancer, 38.9% (7 plant species) were used for cancer of the blood, 33.3% (6 plant species) were used to treat breast cancer, 27.8% (5 plant species) were used for prostate cancer, 16.7% (3 plant species) were used to treat cancer of the colon and a single plant species (5.65%) was useful in treating cancers of the eye and lung cancer in each case. Of all the cited plants species, 44.4% were used to treat all types of cancer.

Table 6 Types of cancer treated by the different traditional medicinal plants

Cited plants’ material preparation/administration for medicinal purposes

As shown in Table 7, the medicinal plants were largely administered to patients as extracts following decoction (66.7%) or infusion (72.2%). The most reported administration route was oral as a decoction, infusion, by chewing or put in tea or porridge. In some instances, plant extracts could be applied as a wash without using a drying towel; and also as fresh leaf sap or fruit macerate onto the affected body area. Tinctures (11.1%) were also prepared and Cannabis sativa L., in addition to its other administration routes, could also be smoked for therapeutic purposes.

Table 7 Plant material preparation/administration for medicinal purposes


There are a number of traditional practitioners (traditional healers, naturopathologists and herbalists) herein collectively termed TMPs, dotted around the country in different provinces. However, getting to these practitioners or getting information from these practitioners was a huge challenge. Nonetheless, some understood the importance of the study and volunteered their knowledge on the subject matter.

The demographics of the study participants are a shown in Table 1. In this study, more male [15] than female [5] practitioners participated.

Initially, the ratio of female to male practitioners who were notified of the study was 1:1,5. However, in the final participants group the ratio came to 1:3 (female to male practitioners). The explanation behind this observation could be that more female than male practitioners were reluctant to give out the information sort for and thus could not take part in the study. Nonetheless, the figures show that the TMPs who treat cancer in Zimbabwe are predominantly males. TMPs who volunteered in the study were from different religion backgrounds, as shown in Table 1. Most of the participants [12] had a Christianity background, followed by traditional religion [6] and lastly, Muslim [2]. This observation dovetails with the general religion distribution in the country where 84% of the population is reported to be Christians [61]. As such, the participant sample reflects a mimicking of TMPs distribution across the religion divide in the country. It also shows that people could still practice traditional medicine regardless of their religion background.

Although all the practitioners claimed to know and understand cancer as a disease, they had varying descriptions of the condition thus its diagnosis varied considerably amongst the practitioners. However, they all concurred to the fact that most patients would consult the TMPs late after being diagnosed of the disease and commenced on conventional treatment. The TMPs highlighted this delay by patients to consult their expertise as one of the contributory factor in cases where their treatments may be deemed to have failed.

Table 2 illustrates the different plants cited by practitioners to be useful in treatment of cancer. Among the most cited plants was Cannabis sativa L. which was used in cancer mainly for its analgesic, anti-nausea and antiemetic properties. Moreover, some claimed it was also helpful in reducing the spread of the disease. The findings dovetail with reports on the medical uses of cannabis elsewhere (Table 3) wherein it is reported that cannabis was found to be useful as an analgesic as well as for chemotherapy-induced nausea and vomiting [25], [62]. The Arab physicians were reported to be users of Cannabis sativa L. extract for its diuretic, anti-emetic, anti-epileptic, anti-inflammatory, analgesic and antipyretic properties. They would also apply the seed oil on to hardened tumours and the tumours would dissolve [26]. There is also evidence of cannabis efficacy in the treatment of insomnia, anxiety and asthma among other uses. Cannabidol, a cannabinoid phytoconstituent, was thought to be responsible for the antipsychotic activity of cannabis [27]. The other use of cannabis in cancer is related to its ability to increase appetite, a phenomenon very useful in cancer patients where appetite is normally suppressed. Scientific studies, though inconclusive, had hinted on the potential efficacy of cannabis as an anti-tumour agent and needed more exploration [62]. Studies on the cannabis plant extract phytoconstituents indicate the presence of over 100 cannabinoids, 9-THC being the most potent and responsible for the psychoactive effects [63]; terpenoids, flavonoids and alkaloids [64]. Given the high frequency index of cannabis in this study, it is prudent to pursue its efficacy in cell growth inhibition or as a cytotoxic agent.

The other most cited plants across the country were Steganotaenia araliacea Hochst., Heteromorpha trifoliata (Wendl.)Eckl. & Zeyh., Kigelia africana (Lam.) Benth., Bulbinella floribunda (Thunb.) T. Durand & Schinz., Solanum incanum L., Pseudolachnostylis maprouneifolia Pax [Agg]. and Burkea africana Hook. as indicated in Table 4. This implies that these medicinal plant species have better use-value than the other plants cited only once in this study. The list of plants obtained and their traditional uses can be compared with what came out of other studies that concentrated on the cytotoxicity of certain medicinal plant extracts. For example, Kigelia africana (Lam.) Benth., highlighted by some practitioners in this study’ has been found from other studies to be useful for skin ailments (eczema, psoriasis, fungal infection, boils), diarrhoea, haemorrhoids, fever, malaria, diabetes as well as having anti-cancer properties [29]. The bioactive constituents found to be present in all the plant parts include iridoids, naphthoquinones, flavonoids, terpenes and pheneylethanoglycosides [29, 65]. The stem bark and fruit extracts were found to be cytotoxic against cancer cell lines [29]. Another study revealed anticancer activity of the fruit extract against cervical and colorectal cancer cell lines [30]. Hibiscus sabdariffa L. and Pseudolachnostylis maprouneifolia Pax [Agg]. have been reported for their use as cytotoxic agents, among other activities [32, 56]. The high polyphenol content in dried leaf extract of Hibiscus sabdariffa L. have been linked to its activity against leukaemia and gastric carcinoma [57]. Studies have also shown Hibiscus sabdariffa L. leaf extract-induced apoptosis in human prostate cancer cells [58]. Other medicinal plants that have been reported for their actual or potential anti-cancer activities include Hypoxis hemerocallidea Fisch.&C.A.Mey [66], [67]., Sutherlandia frutescens (Lam.)R.BR [50]. as well as Solanum incanum L. [54]. Hypoxis hemerocallidea Fisch.&C.A.Mey., also referred to as the miracle plant [68], apart from other documented activities such as hypoglycaemic and antioxidant properties [41]; has been shown to have activity against cancerous and premalignant cancer cells [42]. The herbal extract of Solanum incanum L. has been found to possess anticancer, antinociceptive, antipyretic, antispasmolytic, oretic, hypoglycemic and antimicrobial activities [54]. Notable active components thought to be responsible for the anticancer activity are glycoalkaloids; which include solamargine, solasodine and solasomine. Solarmagine was found to act by inducing cancer cells apoptosis [55]. Cancer bush, Sutherlandia frutescens (L.)R.Br, is native to South Africa and has been traditionally used in the treatment and prophylaxis of cancer [43, 49]. An in-vitro study demonstrated a concentration-dependent inhibition of several tumour cell lines as well as antioxidant activity in reducing free radical cations [49]. Lantana rugosa (camara) Thunb. root and leaf extracts were shown to have activity against cancer cell lines [52] and the plant has been used in folklore medicine for its antipyretic, antimalarial and antimutagenic antitumor, analgesic, antimicrobial and anti-eczema properties [52, 53]. Prunus persica (L.) Batsch. roots, bark, fruits, leaves and flowers found uses in treating haemorrhoids, diarrhoea and the common cold [44]. Its glycosides bioactive constituents were reported to have activity in the inhibition of tumour growth as well as chemoprevention [45]. Other plants highlighted by traditional medicine practitioners in the study that also had anticancer uses or activities reported in elsewhere include Moringa oleifera Lam., Heteromorpha trifoliata (Wendl)Eckl. & Zeyh., Ximenia caffra Sond., Ricinus communis L., Steganotaenia araliacea Hochst., as shown in Table 3. Some plants were not reported for their anticancer activities in literature but were being used to treat cancer by practitioners in this study. Such plants include Duranta erecta L., Asparagus africanus Lam., Bulbinella floribunda (Thunb.) T. Durand & Schinz. and Burkea africana Hook. These plants’ pharmacological significance could be due to the presence of phytoconstituents such as flavonoids, saponins, phenolics, glycosides, alkaloids and tannins in the extracts; which have been found to confer activity against cancer cells. The findings from the present study, therefore, relate to some of the plants’ uses that have been reported by other researchers as demonstrated above. This could be an indication of a strong primary health care provision offered by these TMPs using medicinal plants.

Table 2 shows that the roots and the leaves were the most commonly used plant parts from this study. This is in-sync with other studies where it was also noted that leaves and roots are generally the most frequently used plant parts in traditional medicine [69, 70]. From Table 4, the most treated cancers by the practitioners in this study were cancers of the skin, blood and breast. This trend could be explained from different angles. It could be because blood and skin cancers are also related to other conditions such as the infectious disease, HIV/AIDS, which has a significant prevalence in Zimbabwe. Breast cancer is also one of the most common types of cancer globally and thus very possible for the practitioners to encounter a number of patients suffering from it. Surprisingly, there was no mention of cervical cancer in the study, whose incidence and prevalence has been a cause of concern in the health fraternity in Zimbabwe.

The plants’ material preparation included infusion, decoction, pulverised powder, tinctures and burning for inhalation or smoking. In most cases the plants’ parts would be administered orally as extracts or as pulverised powder in porridge or tea. The practitioners were not clear on the doses administered as well as frequency and duration of treatment. However, generally, the commonly alluded to measure of dose was one to two tablespoonful of either the powder or extract administered twice or three times a day until the condition improves. In cases where patients fail to improve, combination of the plants’ extracts would be administered so as to get additive or synergistic effects. The medicinal plants were reported by participants to be very safe with insignificant adverse effects. Effects such as dizziness and diarrhoea were found to be common in many patients but reported as an indication that ‘the herbs were working’.

Generally, practitioners were not free to give out information. Some were not willing to divulge information about certain medicinal plants, especially the ones they felt the activities to be very powerful. Apparently, such plants serve as the reference trademark of patients from other practitioners and the community at large, hence making them gurus of their trade and earning them community respect as well. Some were adamant to keep this knowledge to themselves as something belonging to their own guarded family secrete and would only divulge to specific chosen family member who would carry own with the legacy. In some of the cases encountered, divulging and/or collection of such information would be subsequent to certain traditional procedures or consultations which would involve some rituals and fees. The major limitation to the study was to do with practitioners’ reluctance with information. Many thought that giving away their knowledge for free would disadvantage them as probably drugs would be discovered from that knowledge without them benefiting from the results. They would rather die with their knowledge or only pass it to their chosen family member who would also hold the information sacredly. Some would only offer their information at a price, for example, a herd of cattle.

Education of TMPC members on the importance of indigenous medicine systems can help researchers in getting important information from TMPs for research purposes much more easily. Also, assistance to the TMPs on issues concerning patents of indigenous knowledge on traditional medicine could go a long way in making sure that indigenous knowledge is preserved and can be accessed by those who may need it whenever they need it.

Unsustainable plant harvesting or collection was found to be rampant among the practitioners, especially where plant roots were of use, thereby posing as a serious threat to plants extinction. There is need for education on sustainable utilisation of plant resources which does not lead to deforestation and extinction of some of the valuable plant species.

A limitation of this study is the small sample size of TMPs who participated. A larger sample size with more participants could have resulted in more plant species being cited as well as broader data and knowledge about medicinal plants use in cancer treatment by TMPs. Follow-up studies with larger sample sizes may yield more indigenous knowledge about plant medicine use in cancer treatment.


TMPs from different areas used different plants for the treatment of the same type of cancer or disease. However, in some cases; similar plants were used by practitioners from different areas. The medicinal plants were used to treat multiple medical conditions by different practitioners. Cancers of the skin, blood and breast were the most commonly treated cancers by practitioners in this study. Roots and leaves were the plant parts mostly used. Oral administration was the most common route of administration by the practitioners, however, other methods of administration such as sap or fruit macerate topical application, body wash and smoking were also utilised. The traditional uses of medicinal plants cited in this study resonate well with those from pharmacological studies on the same plants done in other parts of the world. The work revealed a number of plants used by TMPs to treat cancer which, if explored, may act as templates or leads for cancer drugs discovery and development. Moreover, toxicity studies on these plants need exploration as they may pose potential toxicity in some patients.

Availability of data and materials

All data generated or analysed during this study are included in this article. The materials and data of our study are available to other researchers upon request.



Non-Communicable Diseases


Chemotherapy-Induced Peripheral Neuropathy


World Health Organisation


National Cancer Institute


Indigenous Knowledge Systems


Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome




Deoxyribonucleic Acid


Traditional Medicine Practitioners Council


Ministry of Health and Child Care


Joint Research Ethical Committee for the University of Zimbabwe College of Health Sciences and the Parirenyatwa Group of Hospitals


Medical Research Council of Zimbabwe


Frequency Index


Traditional Medicine Practioners


Sexually Transmitted Infections


  1. 1.

    Domfeh KA. Indigenous knowledge systems and the need for policy and institutional reforms. Tribes Tribals. 2007;1:41–52.

    Google Scholar 

  2. 2.

    Organization WH. Factsheet 134. Traditional medicine: report by the secretariat. Geneva: WHO; 2003.

    Google Scholar 

  3. 3.

    Tilburt JC, Kaptchuk TJ. Herbal medicine research and global health: an ethical analysis. Bull World Health Organ. 2008;86:594–9.

    PubMed  PubMed Central  Google Scholar 

  4. 4.

    Organization WH. The world medicines situation report 2004. No. WHO/EDM/PAR/2004.5. Geneva: World Health Organization; 2004.

    Google Scholar 

  5. 5.

    Payyappallimana U. Role of traditional medicine in primary health care: an overview of perspectives and challenging; 2010.

    Google Scholar 

  6. 6.

    Kambizi L, Afolayan AJ. An ethnobotanical study of plants used for the treatment of sexually transmitted diseases (njovhera) in Guruve District, Zimbabwe. J Ethnopharmacol. 2001;77(1):5–9.

    CAS  PubMed  Google Scholar 

  7. 7.

    Bodeker G, Ong CK, Grundy C, Burford G, Shein K. WHO global atlas of traditional. Complement Altern Med. 2005;1:xiii-xiv.

  8. 8.

    World Health Organisation. Programme on Traditional Medicine. WHO Traditional Medicine Strategy 2002-2005: World Health Organisation; 2002.

  9. 9.

    Cassileth BR, Schraub S, Robinson E, Vickers A. Alternative medicine use worldwide: the International Union against Cancer survey. Cancer. 2001;91(7):1390–3.

    CAS  PubMed  Google Scholar 

  10. 10.

    Verhoef MJ, Balneaves LG, Boon HS, Vroegindewey A. Reasons for and characteristics associated with complementary and alternative medicine use among adult cancer patients: a systematic review. Integr Cancer Ther. 2005;4(4):274–86.

    PubMed  Google Scholar 

  11. 11.

    Manju K, Jat RK, Anju G. A review on medicinal plants used as a source of anticancer agents. Int J Drug Res Technol. 2017;2(2):6.

    Google Scholar 

  12. 12.

    Kung H-C, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep. 2008;56(10):1–120.

    PubMed  Google Scholar 

  13. 13.

    Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–57.

    PubMed  Google Scholar 

  14. 14.

    Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.

    PubMed  PubMed Central  Google Scholar 

  15. 15.

    Tunstall-Pedoe H. Preventing Chronic Diseases. A Vital Investment: WHO Global Report. Geneva: World Health Organization; 2005. p. 200. CHF 30.00. ISBN 92 4 1563001. Also published on Oxford University Press; 2006.

    Google Scholar 

  16. 16.

    Chen M-L, Chu L, Chen H-C. Impact of cancer patients’ quality of life on that of spouse caregivers. Support Care Cancer. 2004;12(7):469–75.

    PubMed  Google Scholar 

  17. 17.

    Mantyh PW. Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci. 2006;7(10):797.

    CAS  PubMed  Google Scholar 

  18. 18.

    Konno B. Integration of traditional medicine with modern medicine. Addis Ababa: EHNRI; 2004. p. 3–9.

    Google Scholar 

  19. 19.

    WHO International Agency for Research on Cancer. IARC Monographs Volume 82; Some traditional herbal medicines. 2002; page 43 - Google Search [Internet]. [cited 2019 Dec 12]. Available from:

  20. 20.

    Maroyi A. An ethnobotanical survey of medicinal plants used by the people in Nhema communal area, Zimbabwe. J Ethnopharmacol. 2011;136(2):347–54.

    PubMed  Google Scholar 

  21. 21.

    Robinson JB, Herbert D. Integrating climate change and sustainable development. Int J Glob Environ Issues. 2001;1(2):130–49.

    Google Scholar 

  22. 22.

    Madikizela B, Ndhlala AR, Finnie JF, Van Staden J. Ethnopharmacological study of plants from Pondoland used against diarrhoea. J Ethnopharmacol. 2012;141(1):61–71.

    CAS  PubMed  Google Scholar 

  23. 23.

    Lino A, Deogracious O. The in-vitro antibacterial activity of Annona senegalensis, Securidacca longipendiculata and Steganotaenia araliacea-Ugandan medicinal plants. Afr Health Sci. 2006;6(1):31–5.

  24. 24.

    Wickramaratne DBM, Pengsuparp T, Mar W, Chai H-B, Chagwedera TE, Beecher CWW, et al. Novel antimitotic dibenzocyclo-octadiene lignan constituents of the stem bark of Steganotaenia araliacea. J Nat Prod. 1993;56(12):2083–90.

    CAS  PubMed  Google Scholar 

  25. 25.

    Machado Rocha FC, Stefano SC, De Cassia HR, Rosa Oliveira LMQ, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl). 2008;17(5):431–43.

    CAS  Google Scholar 

  26. 26.

    Lozano I. The therapeutic use of Cannabis sativa (L.) in Arabic medicine. J Cannabis Ther. 2001;1(1):63–70.

    Google Scholar 

  27. 27.

    Zuardi AW, de Crippa JAS, Hallak JEC, Moreira FA, Guimarães FS. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res. 2006;39(4):421–9.

    CAS  PubMed  Google Scholar 

  28. 28.

    Bonini SA, Premoli M, Tambaro S, Kumar A, Maccarinelli G, Memo M, et al. Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history. J Ethnopharmacol. 2018 Dec 5;227:300–15.

    CAS  PubMed  Google Scholar 

  29. 29.

    Saini S, Kaur H, Verma B, Singh SK. Kigelia africana (Lam.) Benth.—an overview; 2009.

    Google Scholar 

  30. 30.

    Arkhipov A, Sirdaarta J, Rayan P, McDonnell PA, Cock IE. An examination of the antibacterial, antifungal, anti-Giardial and anticancer properties of Kigelia africana fruit extracts. Pharmacogn Commun. 2014;4(3).

  31. 31.

    Gelfand M. The traditional medical practitioner in Zimbabwe: his principles of practice and pharmacopoeia: Mambo Press; 1985.

  32. 32.

    Marekerah L. A survey on the biological activities of selected plants used to manage diarrhoea and cancer in Vumba, Zimbabwe; 2015.

    Google Scholar 

  33. 33.

    Atawodi SE. Antioxidant potential of African medicinal plants. Afr J Biotechnol. 2005;4(2):128–33.

    Google Scholar 

  34. 34.

    Mathisen E, Diallo D, Andersen ØM, Malterud KE. Antioxidants from the bark of Burkea africana, an African medicinal plant. Phytother Res Int J Devoted Pharmacol Toxicol Eval Nat Prod Deriv. 2002;16(2):148–53.

    CAS  Google Scholar 

  35. 35.

    Anwar F, Latif S, Ashraf M, Gilani AH. Moringa oleifera: a food plant with multiple medicinal uses. Phytother Res Int J Devoted Pharmacol Toxicol Eval Nat Prod Deriv. 2007;21(1):17–25.

    CAS  Google Scholar 

  36. 36.

    Fahey JW. Moringa oleifera: a review of the medical evidence for its nutritional, therapeutic, and prophylactic properties. Part 1. Trees Life J. 2005;1(5):1–15.

    Google Scholar 

  37. 37.

    Farooq F, Rai M, Tiwari A, Khan AA, Farooq S. Medicinal properties of Moringa oleifera: an overview of promising healer. J Med Plants Res. 2012;6(27):4368–74.

    Google Scholar 

  38. 38.

    Maroyi A. Ximenia caffra Sond. (Ximeniaceae) in sub-Saharan Africa: a synthesis and review of its medicinal potential. J Ethnopharmacol. 2016;184:81–100.

    PubMed  Google Scholar 

  39. 39.

    Ilavarasan R, Mallika M, Venkataraman S. Anti-inflammatory and free radical scavenging activity of Ricinus communis root extract. J Ethnopharmacol. 2006;103(3):478–80.

    PubMed  Google Scholar 

  40. 40.

    Rana M, Dhamija H, Prashar B, Sharma S. Ricinus communis L.—a review. Int J PharmTech Res. 2012;4(4):1706–11.

    Google Scholar 

  41. 41.

    Oguntibeju OO, Meyer S, Aboua YG, Goboza M. Hypoxis hemerocallidea significantly reduced Hyperglycaemia and Hyperglycaemic-induced oxidative stress in the liver and kidney tissues of Streptozotocin-induced diabetic male Wistar rats. Evid Based Complement Alternat Med. 2016;2016.

  42. 42.

    Drewes SE, Elliot E, Khan F, Dhlamini JTB, Gcumisa MSS. Hypoxis hemerocallidea—not merely a cure for benign prostate hyperplasia. J Ethnopharmacol. 2008;119(3):593–8.

    CAS  PubMed  Google Scholar 

  43. 43.

    Mills E, Cooper C, Seely D, Kanfer I. African herbal medicines in the treatment of HIV: Hypoxis and Sutherlandia. An overview of evidence and pharmacology. Nutr J. 2005;4(1):19.

  44. 44.

    Korkmaz M, Karakuş S. Traditional uses of medicinal plants of Üzümlü district, Erzincan, Turkey. Pak J Bot. 2015;47(1):125–34.

    CAS  Google Scholar 

  45. 45.

    Fukuda T, Ito H, Mukainaka T, Tokuda H, Nishino H, Yoshida T. Anti-tumor promoting effect of glycosides from Prunus persica seeds. Biol Pharm Bull. 2003;26(2):271–3.

    CAS  PubMed  Google Scholar 

  46. 46.

    Subsongsang R, Jiraungkoorskul W. An updated review on phytochemical properties of “Golden dewdrop” Duranta erecta. Pharmacogn Rev. 2016;10(20):115.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. 47.

    Ogbuagu AS, Okoro K, Akpuaka MU, Ogbuagu JO, Ekpunobi UE, Ohaekenyem EC. Extracts of Duranta eracta. Am J Biomed Sci Eng. 2015;1(5):82–7.

    Google Scholar 

  48. 48.

    Musara C, Spies P, Spies JJ, Stedje B. A review of Bulbinella (Asphodelaceae): distribution, conservation status, and economic importance. Bot Sci. 2017;95(2):155–68.

    Google Scholar 

  49. 49.

    Tai J, Cheung S, Chan E, Hasman D. In vitro culture studies of Sutherlandia frutescens on human tumor cell lines. J Ethnopharmacol. 2004;93(1):9–19.

  50. 50.

    Fernandes AC, Cromarty AD, Albrecht C, van Rensburg CEJ. The antioxidant potential of Sutherlandia frutescens. J Ethnopharmacol. 2004;95(1):1–5.

    PubMed  Google Scholar 

  51. 51.

    Van Wyk BE, Albrecht C. A review of the taxonomy, ethnobotany, chemistry and pharmacology of Sutherlandia frutescens (Fabaceae). J Ethnopharmacol. 2008;119(3):620–9.

    PubMed  Google Scholar 

  52. 52.

    Sousa EO, Costa JG. Genus Lantana: chemical aspects and biological activities. Rev Bras Farmacogn. 2012;22(5):1115–80.

    Google Scholar 

  53. 53.

    Kaur R, Kapoor K, Kaur H. Plants as a source of anticancer agents. J Nat Prod Plant Resour. 2011;1(1):119–24.

    Google Scholar 

  54. 54.

    Mwonjoria JK, Ngeranwa JJ, Kariuki HN, Githinji CG, Sagini MN, Wambugu SN. Ethno medicinal, phytochemical and pharmacological aspects of solanum incanum (lin.). Int J Pharmacol Toxicol. 2014;2(2):17–20.

    Google Scholar 

  55. 55.

    Yu S, Sheu H-M, Lee C-H. Solanum incanum extract (SR-T100) induces melanoma cell apoptosis and inhibits established lung metastasis. Oncotarget. 2017;8(61):103509–17.

    PubMed  PubMed Central  Google Scholar 

  56. 56.

    Olaleye MT. Cytotoxicity and antibacterial activity of methanolic extract of Hibiscus sabdariffa. J Med Plants Res. 2007;1(1):9–13.

    Google Scholar 

  57. 57.

    Chiu C-T, Chen J-H, Chou F-P, Lin H-H. Hibiscus sabdariffa leaf extract inhibits human prostate cancer cell invasion via down-regulation of Akt/NF-kB/MMP-9 pathway. Nutrients. 2015;7(7):5065–87.

    PubMed  PubMed Central  Google Scholar 

  58. 58.

    Lin H-H, Chan K-C, Sheu J-Y, Hsuan S-W, Wang C-J, Chen J-H. Hibiscus sabdariffa leaf induces apoptosis of human prostate cancer cells in vitro and in vivo. Food Chem. 2012;132(2):880–91.

    CAS  Google Scholar 

  59. 59.

    Villani T, Juliani HR, Simon JE, Wu Q-L. Hibiscus sabdariffa: Phytochemistry, quality control, and health properties. In: African Natural Plant Products Volume II: Discoveries and Challenges in Chemistry, Health, and Nutrition: American Chemical Society (ACS) Publications; 2013. p. 209–30.

  60. 60.

    Hassan HS, Ahmadu AA, Hassan AS. Analgesic and anti-inflammatory activities of Asparagus africanus root extract. Afr J Tradit Complement Altern Med. 2008;5(1):27–31.

    Google Scholar 

  61. 61.

    Agency (Zimstats) ZNS. Inter-censal demographic survey, 2017. Zimstats Harare, Zimbabwe; 2017.

  62. 62.

    Madras BK. Update of cannabis and its medical use. Rep WHO Expert Comm Drug Depend. 2015; Http://www.Who.Intmedicinesaccesscontrolled-Subst.Pdf.

  63. 63.

    Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456–73.

    CAS  PubMed  Google Scholar 

  64. 64.

    Andre CM, Hausman J-F, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016;7:19.

    PubMed  PubMed Central  Google Scholar 

  65. 65.

    Bello I, Shehu MW, Musa M, Asmawi MZ, Mahmud R. Kigelia africana (lam.) Benth. (sausage tree): Phytochemistry and pharmacological review of a quintessential African traditional medicinal plant. J Ethnopharmacol. 2016;189:253–76.

    CAS  PubMed  Google Scholar 

  66. 66.

    Katerere DR, Eloff JN. Anti-bacterial and anti-oxidant activity of Hypoxis hemerocallidea (Hypoxidaceae): can leaves be substituted for corms as a conservation strategy? South Afr J Bot. 2008;74(4):613–6.

    Google Scholar 

  67. 67.

    Owira PM, Ojewole JA. ‘African potato’(Hypoxis hemerocallidea corm): a plant-medicine for modern and 21st century diseases of mankind?–a review. Phytother Res Int J Devoted Pharmacol Toxicol Eval Nat Prod Deriv. 2009;23(2):147–52.

    CAS  Google Scholar 

  68. 68.

    Van Wyk B-E. The potential of south African plants in the development of new medicinal products. South Afr J Bot. 2011;77(4):812–29.

    Google Scholar 

  69. 69.

    Giday M, Asfaw Z, Elmqvist T, Woldu Z. An ethnobotanical study of medicinal plants used by the Zay people in Ethiopia. J Ethnopharmacol. 2003;85(1):43–52.

    PubMed  Google Scholar 

  70. 70.

    Wondimu T, Asfaw Z, Kelbessa E. Ethnobotanical study of medicinal plants around ‘Dheeraa’town, Arsi zone, Ethiopia. J Ethnopharmacol. 2007;112(1):152–61.

    PubMed  PubMed Central  Google Scholar 

Download references


I would like to acknowledge the following for their assistance; Ms. Guhwa (TMPCZ), Mr. Chapano and Ms. Madondo (National Herbarium/Botanical gardens) and all the traditional medicine practitioners who participated in the study.


The research was self-funded.

Author information




PRM obtained ethical approval from the relevant bodies, structured questionnaires and did the field work and manuscript writing. MG directed the field work and edited the manuscript. LG contributed to the literature review and manuscript editing. CFBN assisted in field work directing, ethical approval guidance and manuscript editing. All the authors have read and approved the manuscript.

Corresponding author

Correspondence to Patrick Rutendo Matowa.

Ethics declarations

Ethics approval and consent to participate

The research was performed in accordance with the Declaration of Helsinki. The Authors complied with the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora. Ethical approval to carry out the research was granted by the Joint Research Ethical Committee for the University of Zimbabwe, College of Health Sciences and the Parirenyatwa Group of Hospitals (JREC) and Medicine Research Council of Zimbabwe (MRCZ). The corresponding approval numbers are JREC/196/18 and A/2439, respectively. Informed consent to participate in the study was obtained from the participants and all the participants signed the informed consent forms.

Consent for publication

Not applicable.

Competing interests

None declared.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Matowa, P.R., Gundidza, M., Gwanzura, L. et al. A survey of ethnomedicinal plants used to treat cancer by traditional medicine practitioners in Zimbabwe. BMC Complement Med Ther 20, 278 (2020).

Download citation


  • Cancer
  • Traditional medicine
  • Traditional medicine practitioners
  • Medicinal plants